Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: A basis for ischemic retinopathy

Cardiovascular Research

Volumn 47, Issue 3, 2000, Pages 489-509

  Hardy, Pierre ^a   Dumont, Isabelle ^a   Bhattacharya, Mousumi ^b   Hou, Xin ^a   Lachapelle, Pierre ^a   Varma, Daya R ^b   Chemtob, Sylvain ^a,b  

^a Departments of Pediatrics   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Blood flow; Free radicals; Nitric oxide; Prostaglandins

Indexed keywords

FREE RADICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZING AGENT; PEROXYNITRITE; PROSTACYCLIN; PROSTANOID; VASCULOTROPIN;

ANGIOGENESIS; EYE BLOOD FLOW; GENETIC TRANSCRIPTION; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINOPATHY; RETROLENTAL FIBROPLASIA; REVIEW; TISSUE OXYGENATION;

CHOROID; DINOPROST; ENDOTHELIAL GROWTH FACTORS; FREE RADICALS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; ISCHEMIA; LIPID PEROXIDATION; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; OXYGEN; RECEPTORS, PROSTAGLANDIN E; RETINA; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034682961     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00084-5     Document Type: Review

References (312)

1. Glass P. Role of light toxicity in the developing retinal vasculature. Birth Defects. 24:1988;103-117.
2. Armstrong D., al-Awadi F. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radic Biol Med. 11:1991;433-436.
3. Penn J.S. Oxygen-induced retinopathy in the rat: a proposed role for peroxidation reactions in the pathogenesis. Teinen-Moslen M., Smith C.V. Free radical mechanisms of tissue injury. 1992;177-188 CRC Press, Boca Raton, FL.
4. Niesman M.R., Johnson K.A., Penn J. Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity. Neurochem Res. 22:1997;597-605.
5. Bonne C., Muller A., Villain M. Free radicals in retinal ischemia. Gen Pharmacol. 30:1998;275-280.
6. Verdejo C., Marco P., Reanau-Piqueras J., Pinazo-Duran M.D. Lipid peroxidation in proliferative vitreoretinopathies. Eye. 13:1999;183-188.
7. Baudouin C., Pisella P.J., Ettaiche M., et al. Effects of EGb761 and superoxide dismutase in an experimental model of retinopathy generated by intravitreal production of superoxide anion radical. Graefe's Arch Clin Exp Ophthalmol. 237:1999;58-66.
8. Flower R.W. Physiology of the developing ocular vasculature. Birth Defects Orig Artic Ser. 24:1988;129-146.
9. Penn J.S. Oxygen-induced retinopathy in the rat: possible contribution of peroxidation reactions. Doc Ophthalmol. 74:1990;179-186.
10. Penn J.S., Tolman B.L., Bullard L.E. Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity. Free Radic Biol Med. 22:1997;977-984.
11. Ashton N. Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies.The XX Francis I. Proctor Lecture. Am J Ophthalmol. 62:1966;412-435.
12. McLeod D.S., Crone S.N., Lutty G.A. Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 37:1996;1322-1333.
13. Aiello L.P., Pierce E.A., Foley E.D., et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA. 92:1995;10457-10461.
14. Berkowitz B.A., Penn J.S. Abnormal panretinal response pattern to carbogen inhalation in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 39:1998;840-845.
15. Penn J.S., Tolman B.L., Henry M.M. Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization. Invest Ophthalmol Vis Sci. 35:1994;3429-3435.
16. Reynaud X., Dorey C.K. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci. 35:1994;3169-3177.
17. Stone J., Itin A., Alon T., et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 15:1995;4738-4747.
18. Alm A., Bill A. The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand. 84:1972;306-319.
19. 2 induce retinal autoregulation in vitro. Graefe's Arch Clin Exp Ophthalmol. 219:1982;6-10.
20. Riva C.E., Grunwald J.E., Sinclair S.H. Laser Doppler velocimetry study of the effect of pure oxygen breathing on retinal blood flow. Invest Ophthalmol Vis Sci. 24:1983;47-51.
21. Chemtob S., Beharry K., Rex J., Chatterjee T., Varma D.R., Aranda J.V. Ibuprofen enhances retinal and choroidal blood flow autoregulation in newborn piglets. Invest Ophthalmol Vis Sci. 32:1991;1799-1807.
22. Hardy P., Abran D., Li D.Y., Fernandez H., Varma D.R., Chemtob S. Free radicals in retinal and choroidal blood flow autoregulation in the piglet: Interaction with prostaglandins. Invest Ophthalmol Vis Sci. 35:1994;580-591.
23. Hardy P., Peri K.G., Lahaie I., Varma D.R., Chemtob S. Increased nitric oxide synthesis and action preclude choroidal vasoconstriciton to hyperoxia in newborn pigs. Circ Res. 79:1996;504-511.
24. 2α receptors on the retinal vasculature of the pig. Prostaglandins. 50:1995;253-267.
25. Hardy P., Nuyt A.M., Abran D., St-Louis J., Varma D.R., Chemtob S. Nitric oxide in retinal and choroidal blood flow autoregulation in newborn pigs: Interaction with prostaglandins. Pediatr Res. 39:1996;487-493.
26. Bougle D., Vert P., Reichart E., Hartmann D., Heng E.L. Retinal superoxide in newborn kittens exposed to normobaric hyperoxia: effect of vitamin E. Pediatr Res. 16:1982;400-402.
27. Nielsen J.C., Naash M.I., Anderson R.E. The regional distribution of vitamins E and C in mature and premature human retinas. Invest Ophthalmol Vis Sci. 29:1988;22-26.
28. Abran D., Varma D.R., Chemtob S. Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides. Am J Physiol. 268:1995;H628-H632.
29. Abran D., Hardy P., Varma D.R., Chemtob S. Mechanisms of the biphasic effects of peroxides on the retinal vasculature of newborn and adult pigs. Exp Eye Res. 61:1995;285-292.
30. Chemtob S., Hardy P., Abran D., et al. Peroxide-cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics. J Appl Physiol. 78:1995;2039-2046.
31. Ginsburg I., Yedgar S., Varani J. Diethyldithiocarbamate and nitric oxide synergize with oxidants and with membrane-damaging agents to injure mammalian cells. Free Radic Res. 27:1997;143-164.
32. Ioannidis I., Batz M., Paul T., Korth H.G., Sustmann R., De Groot H. Enhanced release of nitric oxide causes increased cytotoxicity of S-nitroso-N-acetyl-DL-penicillamine and sodium nitroprusside under hypoxic conditions. Biochem J. 318:1996;789-795.
33. Shaikh A.Y., Xu J., Wu Y., He L., Hsu C.Y. Melatonin protects bovine cerebral endothelial cells from hyperoxia-induced DNA damage and death. Neurosci Lett. 229:1997;193-197.
34. McLeod D.S., Brownstein R., Lutty G.A. Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 37:1996;300-311.
35. Penn J.S., Thum L.A., Naash M.I. Oxygen-induced retinopathy in the rat. Vitamins C and E as potential therapies. Invest Ophthalmol Vis Sci. 33:1992;1836-1845.
36. Raju T.N., Langenberg P., Bhutani V., Quinn G.E. Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J Pediatr. 131:1997;844-850.
37. Peri K.G., Hardy P., Li D.-Y., Varma D.R., Chemtob S. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn. J Biol Chem. 270:1995;24615-24620.
38. Hardy P., Bhatthacharya M., Abran D., et al. Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition. Invest Ophthalmol Vis Sci. 39:1998;1888-1898.
39. 2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development. Circ Res. 80:1997;463-472.
40. Abran D., Varma D.R., Chemtob S. Regulation of prostanoid vasomotor effects and receptors in choroidal vessels of newborn pigs. Am J Physiol. 272:1997;R995-R1001.
41. Hardy P., Abran D., Hou X., et al. A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet. Circ Res. 83:1998;721-729.
42. 2 in the developing choroid. Am J Physiol. 278:2000;H60-H66.
43. 2 receptors. Proc Natl Acad Sci USA. 95:1998;15792-15797.
44. 4 in the nuclear envelope. J Biol Chem. 274:1999;15719-15792.
45. 2. J Pharmacol Exp Ther. 291:1999;627-633.
46. Alm A., Bill A. Ocular circulation. Moses R.A., Hart W.M. Adler's physiology of the eye: clinical application. 1992;198-247 Mosby, St. Louis.
47. Alm A., Bill A. Blood flow and oxygen extraction in the cat uvea at normal and high intraocular pressures. Acta Physiol Scand. 80:1970;19-28.
48. Yu D.Y., Alder V.A., Cringle S.J., Brown M.J. Choroidal blood flow measured in the dog eye in vivo and in vitro by local hydrogen clearance polarography: validation of a technique and response to raised intraocular pressure. Exp Eye Res. 46:1988;289-303.
49. Ashton N. Oxygen and the growth development of retinal vessels. Kimura J., Caygill W.M. Vascular complications of diabetes mellitus; with special emphasis on microangiopathy of the eyes. 1967;3-28 Mosby, St. Louis.
50. Flynn J.T., Bancalari E., Snyder E.S., et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med. 326:1992;1050-1054.
51. Gallo J.E., Jacobson L., Broberger U. Perinatal factors associated with retinopathy of prematurity. Acta Paediatr. 82:1993;829-834.
52. Yu D.Y., Cringle S.J., Alder V.A., Su E.-N., Yu P.K. Intraretinal oxygen distribution and choroidal regulation in the avascular retina of guinea pigs. Am J Physiol. 270:1996;H965-H973.
53. 2 on the oxygen tension in the vitreous body of the cat. Acta Physiol Scand. 84:1972;261-274.
54. Riva C.E., Grunwald J.E., Petrig B. Autoregulation of human retinal blood flow. Invest Ophthalmol Vis Sci. 27:1986;1706-1712.
55. Tachibana H., Gotoh F., Ishikawa Y. Retinal vascular autoregulation in normal subjects. Stroke. 13:1982;149-155.
56. Robinson F., Riva C.E., Grunwald J.E., Petrig B.L., Sinclair S.H. Retinal blood flow autoregulation in response to an acute increase in blood pressure. Invest Ophthalmol Vis Sci. 27:1986;722-726.
57. Kiel J.W., Shepherd A.P. Autoregulation of choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci. 33:1992;2399-2410.
58. Kiel J.W., van Heuven W.A.J. Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci. 36:1995;579-585.
59. Bada H.S., Korones S.B., Perry E.H., et al. Mean arterial blood pressure changes in premature infants and those at risk for intraventricular hemorrhage. J Pediatr. 117:1990;607-614.
60. Shvedova A.A., Alekseeva O.M., Kuliev I.Y.A., Muranov K.O., Kozlov Y.P., Kagan V.E. Damage of photoreceptor membrane lipids and proteins induced by photosensitized generation of singlet oxygen. Curr Eye Res. 2:1982;683-689.
61. Hague S., Hill D.W., Crabtree A. The calibre changes of retinal vessels subject to prolonged hyperoxia. Exp Eye Res. 47:1988;87-96.
62. Hickman J.B., Frayser R. Studies of the retinal circulation in man: Observations on vessel diameter, arteriovenous oxygen difference, and mean circulation time. Circulation. 33:1966;302-316.
63. Peters L.L.H., Sheldon R.E., Jones M.D.J., Battaglia F.C. Retinal and choroidal blood flow in unstressed fetal and neonatal lambs. Pediatr Res. 14:1980;1047-1052.
64. Ricci B. Effects of hyperbaric, normobaric and hypobaric oxygen supplementation on retinal vessels in newborn rats: a preliminary study. Exp Eye Res. 44:1987;459-464.
65. Friedman E., Chandra S.R. Choroidal blood flow. III. Effects of oxygen and carbon dioxide. Arch Ophthalmol. 87:1972;70-71.
66. Campbell W.B. Lipid-derived autacoids:eicosanoids and platelet activating factor. Gileman A.G., Rall T.W., Nies A.S., Taylor P. The pharmacological basis of therapeutics. 1990;600-617 Pergamon Press, New York.
67. Smith W.L. The eicosanoids and their biochemical mechanisms of action. Biochem J. 259:1989;315-324.
68. 2 in RBL-2H3 cells oxidized by tert-butyl hydroperoxide. J Biochem. 125:1999;90-95.
69. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 87:1990;9383-9387.
70. 2-isoprotanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA. 89:1992;10721-10725.
71. Morrow J.D., Minton T.A., Mukundan C.R., et al. Free radical-induced generation of isoprostanes in vivo. J Biol Chem. 269:1994;4317-4326.
72. Campbell W.B., Halushka P.V. Lipid-derived autacoids:eicosanoids and platelet activating factor. Gileman A.G., Rall T.W., Nies A.S., Taylor P. The pharmacological basis of therapeutics. 1996;601-614 Pergamon Press, New York.
73. Smith W.L. Molecular biology of prostanoid biosynthetic enzymes and receptors. Honn K.V. Eicosanoids and other bioactive lipids in cancer, inflammation and radiation injury. 1997;989-1011 Plenum Press, New York.
74. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenase-1 and -2. Annu Rev Pharmacol Toxicol. 38:1998;97-120.
75. Kulmacz R.J., Wang L.H. Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2. J Biol Chem. 270:1995;24019-24023.
76. Shitashige M., Morita I., Murota S. Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts. Biochim Biophys Acta. 1389:1998;57-66.
77. Morita I., Schindler M., Regier M.K., et al. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem. 270:1995;10902-10908.
78. Spencer A.G., Woods J.W., Arakawa T., Singer I.I., Smith W.L. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J Biol Chem. 273:1998;9886-9893.
79. Kennedy I., Coleman R.A., Humphey P.P.A., Levy G.P., Lumley P. Studies on the characterization of prostanoid receptors; a proposed classification. Prostaglandins. 24:1982;667-689.
80. Eglen R.M., Whiting R.L. Characterization of the prostanoid receptor profile of enprosyil and isomers in smooth muscle and platelets in vitro. Br J Pharmacol. 98:1989;1335-1343.
81. Coleman R.A., Smith W.L., Narumiya S. International Union of Pharmacology. Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev. 46:1994;205-229.
82. 2 sensitive (EP) receptors. Br J Pharmacol. 91:1987;1-407.
83. Kotani M., Tanaka I., Ogawa Y., et al. Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3). Genomics. 40:1997;425-434.
84. Halushka P.V., Mais D.E., Mayeux P.R., Morinelli T.A. Thromboxane, prostaglandin and leukotriene receptors. Annu Rev Pharmacol Toxicol. 10:1989;213-239.
85. Abramovitz M., Boie Y., Nguyen T., et al. Cloning and expression of cDNA for the human prostanoid FP receptors. J Biol Chem. 269:1994;2632-2636.
86. Suba E.A., Roth B.L. Prostaglandins activate phosphoinositide metabolism in rat aorta. Eur J Pharmacol. 136:1987;325-332.
87. 1 subtype of prostaglandin E receptor. J Biol Chem. 268:1993;20175-20178.
88. 2 subtype. J Biol Chem. 268:1993;7759-7762.
89. 2 subtype. Invest Ophthalmol Vis Sci. 32:1991;360-365.
90. 2 subtype. Mol Pharmacol. 46:1994;213-220.
91. 3 subtype. J Biol Chem. 267:1992;6463-6466.
92. Namba T., Sugimoto Y., Negishi M., et al. Alternative splicing of C-terminal tail of prostaglandin E receptor EP 3 determines G-protein specificity. Nature. 365:1993;166-170.
93. Birkle D.L., Bazan N.G. Lipoxygenase- and cyclooxygenase-reaction products and incorporation into glycerolipids of radiolabeled arachidonic acid in the bovine retina. Prostaglandins. 27:1984;203-216.
94. Bhattacherjee P., Kulkarni P.S., Eakins K.E. Metabolism of arachidonic acid in rabbit ocular tissues. Invest Ophthalmol Vis Sci. 18:1979;172-178.
95. Kass M.A., Holmberg N.J. Prostaglandin and thromboxane synthesis by microsomes of rabbit ocular tissues. Invest Ophthalmol Vis Sci. 18:1979;166-171.
96. Bazan N.G. Metabolism of arachidonic acid in the retina and retinal pigment epithelium: biological effects of oxygenated metabolites of arachidonic acid. Prog Clin Biol Res. 312:1989;15-37.
97. Parys-VanGinderdeuren R., Malcolm D., Varma D.R., Aranda J.V., Chemtob S. Dissociation between prostaglandin levels and blood flow to the retina and choroid in the newborn pig after nonsteroidal antiinflammatory drugs. Invest Ophthalmol Vis Sci. 33:1992;3378-3384.
98. Abran D., Varma D.R., Li D.-Y., Chemtob S. Reduced responses of retinal vessels of the newborn pig to prostaglandins but not to thromboxane. Can J Physiol Pharmacol. 72:1994;168-173.
99. 3 receptors, regulates brain nitric oxide synthase in the perinatal period. Am J Physiol. 275:1998;R1812-R1821.
100. 4 release in vitro. Curr Eye Res. 14:1995;1001-1008.
101. Asakura T., Matsuda M., Matsuda S., Shichi H. Synthesis of 12(R)- and 12(S)-hydroxyeicosatetraenoic acid by porcine ocular tissues. J Ocul Pharmacol. 10:1994;525-535.
102. Fitzpatrick F.A., Murphy R.C. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of 'epoxygenase'-derived eicosanoids. Pharmacol Rev. 40:1988;229-241.
103. Hurst J.S., Balazy M., Bazan H.E., Bazan N.G. The epithelium, endothelium, and stroma of the rabbit cornea generate (12S)-hydroxyeicosatetraenoic acid as the main lipoxygenase metabolite in response to injury. J Biol Chem. 266:1991;6726-6730.
104. Williams R.N., Bhattacherjee P., Eakins K.E. Biosynthesis of lipoxygenase products by ocular tissues. Exp Eye Res. 36:1983;397-402.
105. Mcmurdo L., Stephenson A.H., Baldassare J.J., Sprague R.S., Lonigro A.J. Biosynthesis of sulfidopeptide leukotrienes via the transfer of leukotriene A4 from polymorphonuclear cells to bovine retinal pericytes. J Pharmacol Exp Ther. 285:1998;1255-1259.
106. Tang D.G., Renaud C., Stojakovic S., Diglio C.A., Porter A., Honn K.V. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem Biophys Res Commun. 211:1995;462-468.
107. Takayama H., Gimbrone M.A. Jr., Schafer A.I. Vascular lipoxygenase activity: synthesis of 15-hydroxyeicosatetraenoic acid form arachidonic acid by blood vessels and cultured vascular endothelial cells. Thromb Res. 45:1987;803-816.
108. Van Diest M.J., Verbeuren T.J., Herman A.G. 15-lipoxygenase metabolites of arachidonic acid evoke contractions and relaxations in isolated canine arteries: role of thromboxane receptors, endothelial cells and cyclooxygenase. J Pharmacol Exp Ther. 256:1991;194-203.
109. Augustin A.J., Grus F.H., Koch F., Spitznas M. Detection of eicosanoids in epiretinal membranes of patients suffering from proliferative vitreoretinal diseases. Br J Ophthalmol. 81:1997;58-60.
110. Mori M., Aihara M., Shimizu T. Localization of platelet-activating factor receptor messenger RNA in the rat eye. Invest Ophthalmol Vis Sci. 38:1997;2672-2678.
111. Lopes-Martins R., Catelli M., Araujo C., Estato V., Cordeiro R., Tibirica E. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure. Eur J Pharmacol. 308:1996;287-294.
112. Bazan H.E., Tao Y., DeCoster M.A., Bazan N.G. Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway. Invest Ophthalmol Vis Sci. 38:1997;2492-2501.
113. Wang M.M., Reynaud D., Pace-Asciak C.R. In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and epoxilins, and actions on vascular permeability. Biochim Biophys Acta. 1436:1999;354-362.
114. Montrucchio G., Lupia E., Battaglia E., et al. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscler Thromb Vasc Biol. 20:2000;80-88.
115. Yamamoto R., Bredt D.S., Snyder S.H., Stone R.A. The localization of nitric oxide synthase in the rat eye and related cranial ganglia. Neuroscience. 54:1993;189-200.
116. Zagvazdin Y.S., Fitzgerald M.E.C., Sancesario G., Reiner A. Neural nitric oxide mediates Edinger-Westphal nucleus evoked increase in choroidal blood flow in the pigeon. Invest Ophthalmol Vis Sci. 37:1996;666-672.
117. Mann R.M., Riva C.E., Stone R.A., Barnes G.E., Cranstoun S.D. Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci. 36:1995;925-930.
118. Radomski M.W., Palmer R.M.J., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 87:1990;5193-5197.
119. Stamler J.S., Singel D.J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 258:1992;1898-1902.
120. Moncada S., Higgs A., Furchgott R. International Union of Pharmacology: nomenclature in nitric oxide research. Pharmacol Rev. 49:1997;137-142.
121. Vincent S.R., Hope B.T. Neurons that say NO. Trends Neurosci. 15:1992;108-113.
122. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770.
123. Goureau O., Lepoivre M., Becquet F., Courtois Y. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor β in bovine retinal pigmented epithelial cells: Inverse correlation with cellular proliferation. Proc Natl Acad Sci USA. 90:1993;4276-4280.
124. Dawson T.M., Bredt D.S., Fotuhi M., Hwang P.M., Snyder S.H. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA. 88:1991;7797-7801.
125. Koistinaho J., Swanson R.A., Vente J.D., Sagar S.M. NADPH-diaphorase (nitric oxide synthase)-reactive amacrine cells of rabbit retina: Putative target cells and stimulation by light. Neuroscience. 57:1993;587-597.
126. Yamamoto R., Bredt D.S., Dawson T.M., Snyder S.H., Stone R.A. Enhanced expression of nitric oxide synthase by rat retina following pterygopalatine parasympathetic denervation. Brain Res. 631:1993;83-88.
127. Koch K., Lambrecht H., Haberecht M., Redburn D., Schimdt H.H.H.W. Functional coupling of a calcium/calmodulin-dependent nitric oxide synthase and a soluble guanyl cyclase in vertebrate photoreceptor cells. EMBO J. 13:1994;3312-3320.
128. Perez M.T.R., Larsson B., Alm P., Anderson K.E., Ehinger B. Localisation of neuronal nitric oxide synthase-immunoreactivity in rat and rabbit retinas. Brain Res. 104:1995;207-217.
129. Chakravarthy U., Stitt A.W., McNally J., Bailie J., Hoey E.M., Duprex P. Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res. 14:1994;285-294.
130. Goureau O., Hicks D., Courtois Y., de Kozak Y. Induction and regulation of nitric oxide synthase in retinal Müller glial cells. J Neurochem. 63:1994;310-317.
131. Park C.S., MacKinnon R. Divalent cation selectivity in a cyclic nucleotide-gated ion channel. Biochemistry. 34:1995;13328-13333.
132. Meyer P., Champion C., Schlotzer-Schrehardt U., Flammer J., Haefliger I.O. Localization of nitric oxide synthase isoforms in porcine ocular tissues. Curr Eye Res. 18:1999;375-380.
133. Donati G., Pournaras C.J., Munoz J., Poitry S., Poitry-Yamate C.L., Tsacopoulos M. Nitric oxide controls arteriolar tone in the retina of the miniature pig. Invest Ophthalmol Vis Sci. 36:1995;2228-2237.
134. Haefliger I.O., Flammer J., Lüscher T.F. Heterogeneity of endothelium-dependent regulation in ophthalmic and ciliary arteries. Invest Ophthalmol Vis Sci. 34:1993;1722-1730.
135. 2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. Exp Eye Res. 49:1989;347-360.
136. Gidday J.M., Zhu Y. Nitric oxide does not mediate autoregulation of retinal blood flow in newborn pig. Am J Physiol. 269:1995;H1065-H1072.
137. Flugel-Koch C., Kaufman P., Lutjen-Drecoll V. Association of a choroidal ganglion cell plexus with the fovea centralis. Invest Ophthalmol Vis Sci. 35:1994;4268-4272.
138. Hardy P., Nuyt A.M., Dumont I., et al. Developmentally increased cerebrovascular NO in newborn pigs curtails cerebral blood flow autoregulation. Pediatr Res. 46:1999;375-382.
139. Rubanyi G.M., Romero J.C., Vanhoutte P.M. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 250:1986;H1145-H1149.
140. Lizasoain I., Weiner C.P., Knowles R., Moncada S. The ontogeny of cerebral and cerebellar nitric oxide synthase in the guinea pig and rat. Pediatr Res. 39:1996;779-783.
141. Ostwald P., Goldstein I.M., Pachnanda A., Roth S. Effect of nitric oxide synthase inhibition on blood flow after retinal ischemia in cats. Invest Ophthalmol Vis Sci. 36:1995;2396-2403.
142. Korbut R., Ocetkiewicz A., Gryglewski R.J. Nitric oxide complements prostacyclin in the regulation of endothelial thromboresistance under flow conditions. Method Find Exp Clin Pharmacol. 15:1993;179-181.
143. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA. 90:1993;7240-7244.
144. Tsai A.-L., Wei C., Kulmacz R.J. Interaction between nitric oxide and prostaglandin H synthase. Arch Biochem Biophys. 313:1994;367-372.
145. Geller D.A., Nussler A.K., Di Silvio M., et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA. 90:1993;522-526.
146. Plochocka-Zulinska D., Krukoff T.L. Increased gene expression of neuronal nitric oxide synthase in brain of adult spontaneously hypertensive rats. Mol Brain Res. 48:1997;291-297.
147. Le Greves P., Sharma H.S., Westman J., Alm P., Nyberg F. Acute heat stress induces edema and nitric oxide synthase upregulation and down-regulates mRNA levels of the NMDAR1, NMDAR2A and NMDAR2B subunits in the rat hippocampus. Acta Neurochir Suppl. 70:1997;275-278.
148. Garcia-Duran M., de Frutos T., Diaz-Recasens J., et al. Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils. Circ Res. 85:1999;1020-1026.
149. Alonso J., Sanchez de Miguel L., Monton M., Casado S., Lopez-Farré A. Endothelial cytosolic proteins bind to the 3′ untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha. Mol Cell Biol. 17:1997;5719-5726.
150. MacRitchie A.N., Jun S.S., Chen Z., et al. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res. 81:1997;355-362.
151. Sessa W.C., Garcia-Cardena G., Liu J., et al. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem. 270:1995;17641-17644.
152. Karantzoulis-Fegaras F., Antoniou H., Lai S.L., et al. Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem. 274:1999;3076-3093.
153. Nichida K., Harrison D.G., Navas J.P., et al. Molecular cloning and characterization of constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest. 90:1992;2092-2096.
154. Yoshizumi M., Perella M.A., Brunett J.C., Lee M.E. Tumor necrosis factor down regulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 73:1993;205-209.
155. McQuillan L.P., Leung G.K., Marsden P.A., Kostyk S.K., Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and postranscriptional mechanisms. Am J Physiol. 267:1994;H1921-H1927.
156. Johns R.A., Linden J.M., Peach M.J. Endothelium dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ Res. 65:1989;1508-1515.
157. 2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem. 270:1995;30749-30754.
158. Rao C.V., Mitra S. Gonadotropin and prostaglandins binding sites in nuclei of bovine corpora lutea. Biochim Biophys Acta. 584:1979;454-466.
159. Kanai N., Lu R., Satriano J.A., Bao Y., Wolkoff A.W., Schuster V.L. Identification and characterization of a prostaglandin transporter. Science. 268:1995;866-869.
160. Lu R., Kanai N., Bao Y., Schuster V.L. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA (hPGT). J Clin Invest. 98:1996;1142-1149.
161. Schuster V.L. Molecular mechanisms of prostaglandin transport. Annu Rev Physiol. 60:1998;221-242.
162. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 87:1990;1620-1624.
163. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 271:1996;C1424-C1437.
164. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol. 9:1996;836-844.
165. Squadrito G.L., Pryor W.A. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med. 25:1998;392-403.
166. Wink D.A., Mitchell J.B. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med. 25:1998;434-456.
167. Squadrito G.L., Pryor W.A. The nature of reactive species in systems that produce peroxynitrite. Chem Res Toxicol. 11:1988;718-719.
168. Grisham M.B., Jourd'Heuil D., Wink D.A. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites:implications in inflammation. Am J Physiol. 276:1999;G315-G321.
169. Lefer A.M. Therapeutic role of nitric oxide donors in the treatment of cardiovascular disease. Drugs Future. 19:1994;665-672.
170. Lefer A.M. Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy. Ann Thorac Surg. 60:1995;847-851.
171. Vinten-Johansen J., Sato H., Zhao Z.-Q. The role of nitric oxide and NO-donor agents in myocardial protection from surgical ischemic-reperfusion injury. Int J Cardiol. 50:1995;273-281.
172. Vinten-Johansen J., Zhao Z.-Q., Sato H. Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy. Ann Thorac Surg. 60:1995;852-857.
173. Ronson R.S., Nakamura M., Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res. 44:1999;47-59.
174. Rubbo H., Radi R., Trujillo M., et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem. 269:1994;26066-26075.
175. Ishii M., Shimizu S., Yamamoto T., Momose K., Kuroiwa Y. Acceleration of oxidative stress-induced endothelial cell death by nitric oxide synthase dysfunction accompanied with decrease in tetrahydrobiopterin content. Life Sci. 61:1997;739-747.
176. Wever R.M.F., van Dam T., van Rijn H.J., de Groot F., Rabelink T.J. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun. 237:1997;340-344.
177. Huk I., Nanobashvili J., Neumayer C., et al. L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation. 96:1997;667-675.
178. Huk I., Brovkovych V., Nanobashvili J., et al. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br J Surg. 85:1998;1080-1085.
179. Zou M., Martin C., Ullrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem. 378:1997;707-713.
180. Darley-Usmar V.M., Hogg N., O'Leary V.J., Wilson M.T., Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun. 17:1992;9-20.
181. Zingarelli B., Day B.J., Crapo J.D., Salzman A.L., Szabo C. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol. 120:1997;259-267.
182. Ghafourifar P., Schenk U., Klein S.D., Richter C. Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. J Biol Chem. 274:1999;31185-31188.
183. Estevez A.G., Crow J.P., Sampson J.B., et al. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science. 286:1999;2498-2500.
184. Goureau O., Regnier-Richard F., Courtois Y. Requirement for nitric oxide in retinal neuronal cell death induced by activated Muller glial cells. J Neurochem. 72:1999;2506-2515.
185. Sharov V.S., Briviba K., Sies H. Peroxynitrite diminishes gap junctional communication: protection by selenite supplementation. IUBMB Life. 48:1999;379-384.
186. Ashton A.W., Yokota R., John G., et al. Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2). J Biol Chem. 274:1999;35562-35570.
187. Marumo T., Noll T., Schini-Kerth V.B., et al. Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor. J Vasc Res. 36:1999;510-515.
188. Shimizu K., Wu G.S., Sultana C., Kalra V.K., Rao N.A. Stimulation of macrophages by retinal protein: production of reactive nitrogen and oxygen metabolites. Invest Ophthalmol Vis Sci. 40:1999;3215-3223.
189. Reisner D.S., Hansen R.M., Findl O., Petersen R.A., Fulton A.B. Dark-adapted thresholds in children with histories of mild retinopathy of prematurity. Invest Ophthalmol Vis Sci. 38:1997;1175-1183.
190. Reynaud X., Hansen R.M., Fulton A.B. Effect of prior oxygen exposure on the electroretinographic responses of infant rats. Invest Ophthalmol Vis Sci. 36:1995;2071-2079.
191. Lachapelle P., Dembinska O., Rojas L.M., Benoit J., Almazan G., Chemtob S. Persistent functional and structural retinal anomalies in newborn rats exposed to hyperoxia. Can J Physiol Pharmacol. 77:1999;48-55.
192. Fulton A.B., Hansen R.M. Photoreceptor function in infants and children with a history of mild retinopathy of prematurity. J Opt Soc Am A. 13:1996;566-571.
193. Fulton A.B., Reynaud X., Hansen R.M., Lemere C.A., Parker C., Williams T.P. Rod photoreceptors in infant rats with a history of oxygen exposure. Invest Ophthalmol Vis Sci. 40:1999;168-174.
194. Bonini M.G., Radi R., Ferrer-Sueta G., Ferreira A.M., Augusto O. Direct EPR detection of the carbonate radical anion produced from peroxynitrite and carbon dioxide. J Biol Chem. 274:1999;10802-10806.
195. Gow A., Duran D., Thom S.R., Ischiropoulos H. Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch Biochem Biophys. 333:1996;42-48.
196. Halliwell B., Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186:1990;1-85.
197. Flaherty J.T., Weisfeldt M.L. Reperfusion injury. Free Radic Biol Med. 5:1988;409-419.
198. Southorn P.A., Powis G. Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin Proc. 63:1988;381-389.
199. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 11:1991;81-128.
200. Comporti M. Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology. Free Radic Res. 28:1998;623-635.
201. Keller J.N., Hanni K.B., Markesbery W.R. 4-Hydroxynonenal increases neuronal susceptibility to oxidative stress. J Neurosci Res. 58:1999;823-830.
202. Mylonas C., Kouretas D. Lipid peroxidation and tissue damage. In Vivo. 13:1999;295-309.
203. Buko V.U., Artsukevich A.A., Ignatenko K.V. Aldehydic products of lipid peroxidation inactivate cytochrome P-450. Exp Toxicol Pathol. 51:1999;294-298.
204. Hanna N., Peri K.G., Abran D., et al. Light induces peroxidation in retina by activating prostaglandin G/H synthase. Free Radic Biol Med. 23:1997;885-897.
205. Oliver P.D., Newsome D.A. Mitochondrial superoxide dismutase in mature and developing human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 33:1992;1909-1918.
206. Chen W., Hunt D.M., Lu H., Hunt R.C. Expression of antioxidant protective proteins in the rat retina during prenatal and postnatal development. Invest Ophthalmol Vis Sci. 40:1999;744-751.
207. Connor J.R., Pavlick G., Karli D., Menzies S.L., Palmer C. A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol. 355:1995;111-123.
208. Palmer C., Menzies S.L., Roberts R.L., Pavlick G., Connor J.R. Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res. 56:1999;60-71.
209. Egan R.W., Gale P.H., Baptista E.M., et al. Oxidation reactions by prostaglandin cyclooxygenase-hydroperoxidase. J Biol Chem. 256:1981;7352-7361.
210. Freeman B.A., Crapo J.D. Biology of disease free radicals and tissue injury. Lab Invest. 47:1982;412-426.
211. Kukreja R.C., Kontos H.A., Hess M.L., Ellis E.F. PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res. 59:1986;612-619.
212. Moncada S., Palmer R.M.J., Higgs E.A. Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol. 38:1989;1709-1715.
213. Chemtob S., Roy M.-S., Abran D., Fernandez H., Varma D.R. Prevention of post-asphyxial increase in lipid peroxides and retinal function deterioration in the newborn pig, by inhibition of cyclooxygenase activity and free radical generation. Pediatr Res. 33:1993;336-340.
214. Nandgaonkar B.N., Rotschild T., Yu K., Higgins R.D. Indomethacin improves oxygen-induced retinopathy in the mouse. Pediatr Res. 46:1999;184-188.
215. Kondo T., Kinouchi H., Kawase M., Yoshimoto T. Differential response in the release of hydrogen peroxide between astroglial cells and endothelial cells following hypoxia/reoxygenation. Neurosci Lett. 215:1996;103-106.
216. Wei E.P., Kontos H.A., Dietrich W., Povlishock J.T., Ellis E.F. Inhibition by free radicals scavengers and cyclooxygenase inhibitors of pial arteriolar abnormalities from concussive brain injury cats. Circ Res. 48:1981;95-103.
217. Proctor K.G., Duling B.R. Oxygen-derived free radicals and local control of striated muscle blood flow. Microvasc Res. 24:1982;77-86.
218. Rosenblum V.I. Effects of free radical generation on mouse pial arterioles: possible role of hydroxyl radicals. Am J Physiol. 245:1983;H139-H142.
219. Kontos H.A., Wei E.P., Povlishock J.T., Christman C.W. Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats. Circ Res. 55:1984;292-303.
220. Tate R.M., Morris H.G., Schroeder W., Repine J.E. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. J Clin Invest. 74:1984;608-613.
221. Rubanyi G.M. Vascular effects of oxygen-derived free radicals. Free Radic Biol Med. 4:1988;107-120.
222. 2 effects on cerebral prostanoids and pial arteriolar diameter in piglets. Am J Physiol. 258:1990;H1382-H1387.
223. Cristol J.P., Thiemermann C., Mitchell J., Walder C., Vane J.R. Support of renal blood flow after ischemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites. Br J Pharmacol. 109:1993;188-194.
224. Koide T., Neichi T., Takato M., et al. Possible mechanisms of 15-hydroperoxy arachidonic acid-induced contraction of the canine basilar artery in vitro. J Pharmacol Exp Ther. 221:1982;481-488.
225. Rubanyi G.M., Vanhoutte P.M. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol. 250:1986;H815-H821.
226. Wolin M.S., Rodenburg J.M., Messina E.J., Kaley G. Oxygen metabolites and vasodilator mechanisms in rat cremasteric arterioles. Am J Physiol. 252:1987;H1159-H1163.
227. Walsh S.W., Wang Y., Jesse R. Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane. Am J Obstet Gynecol. 169:1993;1007-1012.
228. Hubel C.A., Davidge S.T., McLaughlin M. Lipid hydroperoxides potentiate mesenteric artery vasoconstrictor responses. Free Radic Biol Med. 14:1993;397-407.
229. 2. Ciba Found Symp. 78:1980;165-183.
230. 2 balance: pathophysiological and therapeutic implications. Br Med Bull. 39:1983;271-276.
231. Gurtner G.H., Knoblauch A., Smith P.L., Sies H., Adkinson N.F. Jr. Oxidant- and lipid-induced pulmonary vasoconstriction mediated by arachidonic acid metabolites. J Appl Physiol. 55:1983;949-954.
232. Vane J.R., Anggard E.E., Botting R. Regulatory functions of the vascular endothelium. N Engl J Med. 323:1990;27-36.
233. Hemler M.E., Cook H.W., Lands W.E. Prostaglandin biosynthesis can be triggered by lipid peroxides. Arch Biochem Biophys. 193:1979;340-345.
234. Kulmacz R.J., Lands W.E.M. Prostaglandin H synthase: stoichiometry of heme cofactor. J Biol Chem. 259:1984;6358-6363.
235. Smith W.L. Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. Annu Rev Physiol. 48:1986;251-262.
236. Harlan J.M., Callahan K.S. Role of hydrogen peroxide in the neutrophil-mediated release of prostacyclin from cultured endothelial cells. J Clin Invest. 74:1984;442-448.
237. Schimke I., Griesmacher A., Weigel G., Holshutter H., Muller M.M. Effects of reactive oxygen species on eicosanoid metabolism in human endothelial cells. Prostaglandins. 43:1992;281-292.
238. Davidge S.T., Hubel C.A., McLaughlin M. Cyclooxygenase-dependent vasoconstrictor alters vascular function in the vitamin E-deprived rat. Circ Res. 73:1993;79-88.
239. Feng L., Xia Y., Garcia G.E., Hwang D., Wilson C.B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest. 95:1995;1669-1675.
240. Weiss S.J., Turk J., Needleman P. A mechanism for the hydroperoxide-mediated inactivation of prostacyclin synthetase. Blood. 53:1979;1191-1196.
241. Williams C.S., DuBois R.N. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol. 270:1996;G393-G400.
242. Natarajan V. Oxidants and signal transduction in vascular endothelium. J Lab Clin Med. 125:1995;26-37.
243. Hsi L.C., Hoganson C.W., Babcock G.T., Garavito R.M., Smith W.L. An examination of the source of the tyrosyl radical in ovine prostaglandin endoperoxide synthase-1. Biochem Biophys Res Commun. 207:1995;652-660.
244. Picot D., Loll P.J., Garavito R.M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 367:1994;243-249.
245. Hempel S.L., Monick M.M., He B., Yano T., Hunninghake G.W. Synthesis of prostaglandin H synthase-2 by human alveolar macrophages in response to lipopolysaccharide is inhibited by decreased cell oxidant tone. J Biol Chem. 269:1994;32979-32984.
246. Kosaka T., Miyata A., Ihara H., et al. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem. 221:1994;889-897.
247. 2 in pulmonary endothelium. Am J Physiol. 257:1989;L430-L437.
248. Mabile L., Fitoussi G., Periquet B., Schmitt A., Salvayre R., Negre-Salvayre A. Alpha-Tocopherol and trolox block the early intracellular events (TBARS and calcium rises) elicited by oxidized low density lipoproteins in cultured endothelial cells. Free Radic Biol Med. 19:1995;177-187.
249. DeHass G.H., Postema N.M., Nieuwenhuizen M., Van Deenen L.L.M. Purification and properties of an anionic zymogen of phospholipase A from porcine pancreas. Biochim Biophys Acta. 159:1968;118-129.
250. Rashba-Step J., Tatoyan A., Duncan R., Ann D., Pushpa-Rehka T.R., Sevanian A. Phospholipid peroxidation induces cytosolic phospholipase A2 activity: membrane effects versus enzyme phosphorylation. Arch Biochem Biophys. 343:1997;44-454.
251. McLean L.R., Hagaman K.A., Davidson W.S. Role of lipid structure in the activation of phospholipase A2 by peroxidized phospholipids. Lipids. 28:1993;505-509.
252. Shasby D.M., Yorek M., Shasby S. Exogenous oxidants initiate hydrolysis of endothelial cell inositol phospholipids. Blood. 72:1988;491-499.
253. Moore K., Roberts L.J. II. Measurement of lipid peroxidation. Free Radic Res. 28:1998;659-671.
254. Roberts L.J. II, Morrow J.D. The generation and actions of isoprostanes. Biochim Biophys Acta. 1345:1997;121-135.
255. Morrow J.D., Roberts L.J. II. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol. 51:1996;1-9.
256. 2∝. J Biol Chem. 270:1995;9800-9808.
257. Lahaie I., Hardy P., Hou X., et al. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am J Physiol. 274:1998;R1406-R1416.
258. Morrow J.D., Chen Y., Brame C.J., et al. The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab Rev. 31:1999;117-139.
259. Fukunaga M., Makita N., Roberts L.J. II, Morrow J.D., Takahashi K., Badr K.F. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol. 264:1993;C1619-C1624.
260. Fukunaga M., Yura T., Grygorczyk R., Badr K.F. Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2. Am J Physiol. 272:1997;F477-F483.
261. Longmire A.W., Roberts L.J., Morrow J.D. Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. Prostaglandins. 48:1994;247-256.
262. Pratico D., Smyth E.M., Violi F., FitzGerald G.A. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms. J Biol Chem. 271:1996;14916-14924.
263. Hou X., Gobeil F. Jr., Peri K. Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels. Stroke. 31:2000;516-525.
264. Martinez-Bermudez K., Almazan G., Lachapelle P., et al. Isoprostanes induce retinal vasoobliteration, a key feature of retinopathy of prematurity. Pediatr Res. 45:1999;210A.
265. Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol. 36:1992;373-384.
266. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 161:1989;851-858.
267. Gospodarowicz D., Plouet J., Fujii D.K. Ovarian germinal epithelial cells respond to basic fibroblast growth factor and express its gene: implications for folliculogenesis. Endocrinology. 125:1989;1266-1276.
268. Leung D.W. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
269. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrinol Rev. 18:1997;4-25.
270. Millauer B., Wizigmann-Voos S., Schnurch H., et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:1993;835-846.
271. Plate K.H., Breier G., Weich H.A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 359:1992;845-848.
272. Pierce E.A., Avery R.L., Foley E.D., Aiello L.P., Smith L.E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 92:1995;905-909.
273. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.
274. Dorey C.K., Aouididi S., Reynaud X., Dvorak H.F., Brown L.F. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol. 114:1996;1210-1217.
275. Robbins S.G., Rajaratnam V.S., Penn J.S. Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina. Growth Factors. 16:1998;1-9.
276. Aiello L.P., Pierce E.A., Foley E.D., et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA. 92:1995;10457-10461.
277. Aiello L.P., Avery R.L., Arrigg P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 331:1994;1480-1487.
278. Malecaze F., Clamens S., Simorre-Pinatel V., et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol. 112:1994;1476-1482.
279. Tsai J.C., Goldman C.K., Gillespie G.Y. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg. 82:1995;864-873.
280. 1 in osteoblasts. J Clin Invest. 93:1994;2490-2496.
281. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 267:1992;10931-10934.
282. Feng Y., Venema V.J., Venema R.C., Tsai N., Caldwell R.B. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun. 256:1999;192-197.
283. Ghiso N., Rohan R.M., Amano S., Garland R., Adamis A.P. Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP. Invest Ophthalmol Vis Sci. 40:1999;1033-1039.
284. Mayhan W.G. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol. 276:1999;C1148-C1153.
285. Bouloumie A., Schini-Kerth V.B., Busse R. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res. 41:1999;773-780.
286. He H., Venema V.J., Gu X., Venema R.C., Marrero M.B., Caldwell R.B. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem. 274:1999;25130-25135.
287. Shen B.Q., Lee D.Y., Zioncheck T.F. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem. 274:1999;33057-33063.
288. Kroll J., Waltenberger J. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Biochem Biophys Res Commun. 265:1999;636-639.
289. Kimura H., Weisz A., Kurashima Y., et al. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood. 95:2000;189-197.
290. Marumo T., Noll T., Schini-Kerth V.B., et al. Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor. J Vasc Res. 36:1999;510-515.
291. Shizukuda Y., Tang S., Yokota R., Ware J.A. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity. Circ Res. 85:1999;247-256.
292. Hood J.D., Meininger C.J., Ziche M., Granger H.J. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol. 274:1998;H1054-H1058.
293. Murohara T., Horowitz J.R., Silver M., et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 97:1998;99-107.
294. Papapetropoulos A., Garcia-Cardena G., Madri J.A., Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 100:1997;3131-3139.
295. Morbidelli L., Chang C.H., Douglas J.G., Granger H.J., Ledda F., Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol. 270:1996;H411-H415.
296. Tsurumi Y., Murohara T., Krasinski K., et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med. 3:1997;879-886.
297. Frank S., Stallmeyer B., Kampfer H., Kolb N., Pfeilschifter J. Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J. 13:1999;2002-2014.
298. 2 in rat heart endothelial cells. Free Radic Biol Med. 25:1998;891-897.
299. Kuroki M., Voest E.E., Amano S., et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest. 98:1996;1667-1675.
300. Helfman T., Falanga V. Gene expression in low oxygen tension. Am J Med Sci. 306:1993;37-41.
301. Phillips P.G., Birnby L.M., Narendran A. Hypoxia induces capillary network formation in cultured bovine pulmonary microvessel endothelial cells. Am J Physiol. 268:1995;L789-L800.
302. Bolanos J.P., Almeida A. Roles of nitric oxide in brain hypoxia-ischemia. Biochim Biophys Acta. 1411:1999;415-436.
303. Justice J.M., Tanner M.A., Myers P.R. Endothelial cell regulation of nitric oxide production during hypoxia in coronary microvessels and epicardial arteries. J Cell Physiol. 182:2000;359-365.
304. Dildy G.A., van den Berg P.P., Katz M., et al. Intrapartum fetal pulse oximetry: Fetal oxygen saturation trends during labor and relation to delivery outcome. Am J Obstet Gynecol. 171:1994;679-684.
305. Chua S., Yeong S.M., Razvi K., Arulkumaran S. Fetal oxygen saturation during labour. Br J Obstet Gynaecol. 104:1997;1080-1083.
306. Lipton S.A., Choi Y.-B., Pan Z.-H., et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
307. Fineman J.R., Wong J., Morin F.C. III, Wild L.M., Soifer S.J. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest. 93:1994;2675-2683.
308. Rudinsky B., Bell A., Hipps R., Meadow W. Relative contribution of endothelium-derived relaxation factor to vascular tone in the systemic, pulmonary, and cerebral circulations of piglets. Dev Pharmacol Ther. 20:1993;152-161.
309. Pettigrew L.C., Grotta J.C., Rhoades H.M., Wu K.K. Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain. Stroke. 20:1989;627-632.
310. Akaike A., Kaneko S., Tamura Y., et al. Prostaglandin E2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 663:1994;237-243.
311. Dobson V., Quinn G.E., Abramov I., et al. Color vision measured with pseudoisochromatic plates at five-and-a-half years in eyes of children from the CRYO-ROP study. Invest Ophthalmol Vis Sci. 37:1996;2467-2474.
312. McLeod D.S., D'Anna S.A., Lutty G.A. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy. Invest Ophthalmol Vis Sci. 39:1998;1918-1932.